Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Amortization of Deferred Charges: 2019-2020

Historic Amortization of Deferred Charges for Neurogene (NGNE) over the last 2 years, with Sep 2020 value amounting to $253,000.

  • Neurogene's Amortization of Deferred Charges rose 954.17% to $253,000 in Q3 2020 from the same period last year, while for Sep 2020 it was $808,000, marking a year-over-year change of. This contributed to the annual value of $320,000 for FY2014, which is 2185.71% up from last year.
  • Latest data reveals that Neurogene reported Amortization of Deferred Charges of $253,000 as of Q3 2020, which was up 8,333.33% from $3,000 recorded in Q2 2020.
  • Neurogene's 5-year Amortization of Deferred Charges high stood at $528,000 for Q1 2020, and its period low was $3,000 during Q2 2020.
  • For the 2-year period, Neurogene's Amortization of Deferred Charges averaged around $143,333, with its median value being $27,500 (2019).
  • Examining YoY changes over the last 5 years, Neurogene's Amortization of Deferred Charges showed a top increase of 2,414.29% in 2020 and a maximum decrease of 90.32% in 2020.
  • Quarterly analysis of 2 years shows Neurogene's Amortization of Deferred Charges stood at $24,000 in 2019, then skyrocketed by 954.17% to $253,000 in 2020.
  • Its last three reported values are $253,000 in Q3 2020, $3,000 for Q2 2020, and $528,000 during Q1 2020.